Category

Featured

“Finding Your Way From Patent Value to Return-On-Investment. A Patent Strategy Case Study.” Richardson et. al. IPWatchdog (August 2017)

By | Featured, Publication | No Comments

Our client’s executive team needed to better understand the investment and expected risk reduction return from their patent portfolio. We helped them build a financial model and direct their patent strategy using an approach where we identified and maximized patent value.

“Finding Your Way From Patent Value to Return-On-Investment. A Patent Strategy Case Study.” Richardson et. al. IPWatchdog (August 2017), available here.

Richardson and Oliver Selected for the Top 300 IP Strategists

By | Featured, News | No Comments

Kent Richardson and Erik Oliver are proud and humbled to be selected for the ninth and eighth years respectively for IAM’s Top 300 IP Strategists. From IAM Magazine, “It is a pleasure to welcome you to the 2017 edition of IAM Strategy 300 – The World’s Leading IP Strategists, our annual listing of individuals who our research has revealed specialise in developing and rolling out world-class IP value creation programmes.” You can read more here.

Patent Purchases and Litigation Outcomes with Mark Lemley et al., Patenly-O Law Journal

By | Featured, News | No Comments

The sales market for patent rights continues to vex analysts – especially in terms of valuation. In their Patently-O Patent Law Journal article, Professor Mark Lemley teams up with the Richardson Oliver Law Group to provide further guidance.  The article considers how patent litigation outcomes vary according to the identity of the patentee (ownership) and the manner in which the patent was obtained (source), read the article at Patently-O.

Bloomberg BNA Publishes ROL Group Second Quarter Patent Market Data

By | Featured, News | No Comments

Bloomberg/BNA has published its second quarter analysis of the ROL Group patent market data. Our data continues to be a valuable resource for those seeking to buy or sell patents. Our latest annual report can be downloaded here.

“… Possibly the largest asset transfer during the quarter involved two packages containing 261 U.S.-issued patents sold by Wilk Patent Development Corp. and its president, Peter J. Wilk, to CHF Technologies Inc., which does business as BioVentrix Inc., a cardiovascular device firm.

Wilk previously sought to sell about 25 cardiovascular patent assets on the brokered market through ICAP Patent Brokerage, according to a September 2015 press release. The patents “pertain to heart and vascular surgery, cardiothoracic surgery, coronary artery bypass procedures” and numerous other cardiovascular procedures, according to the release.

Because of the PTO recording lag, it’s not clear how many of the Wilk patents BioVentrix actually purchased.

Twitter also purchased patent assets from the defensive patent aggregation firm Allied Security Trust during the quarter. The package included 14 patent assets, including 7 U.S.-issued patents.”